Cognitive-behavioral stress management intervention effects on anxiety, 24-hr urinary norepinephrine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men

Journal of Consulting and Clinical Psychology

Volumn 68, Issue 1, 2000, Pages 31-45

  Antoni, Michael H ^a   Cruess, Dean G ^b   Cruess, Stacy ^b   Lutgendorf, Susan ^b   Kumar, Mahendra ^b   Ironson, Gail ^b   Klimas, Nancy ^b   Fletcher, Mary Ann ^b   Schneiderman, Neil ^b  

^a Department of Biology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN;

ADULT; AFFECTIVE NEUROSIS; ANGER; ANXIETY NEUROSIS; ARTICLE; BEHAVIOR THERAPY; CATECHOLAMINE URINE LEVEL; CELLULAR IMMUNITY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HOME CARE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RELAXATION TRAINING; SUPPRESSOR CELL;

EID: 0034056285     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0022-006X.68.1.31     Document Type: Article

References (108)

1. Ader, R., Felten, D., & Cohen, N. (1991). Psychoneuroimmunology (2nd ed.). New York: Academic Press.
2. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.
3. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
4. Antoni, M. H., Baggett, L., Ironson, G., August, S., LaPerriere, A., Klimas, N., Schneiderman, N., & Fletcher, M. A. (1991). Cognitive behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity. Journal of Consulting and Clinical Psychology, 59, 906-915.
5. Antoni, M. H., & Schneiderman, N. (1998). HIV/AIDS. In A. Bellack & M. Hersen (Eds.), Comprehensive clinical psychology (pp. 237-275). New York: Elsevier Science.
6. Antoni, M. H., Schneiderman, N., Fletcher, M., Goldstein, D., Laperriere, A., & Ironson, G. (1990). Psychoneuroimmunology and HIV-1. Journal of Consulting and Clinical Psychology, 58, 38-49.
7. Antoni, M. H., Schneiderman, N., & Ironson, G. (1998). Stress management for HIV infection. Unpublished manuscript, University of Miami, Coral Gables, FL.
8. Asian, S., Nelson, L., Caruthers, N., & Lader, M. (1981). Stress and age effects on catecholamines in normal subjects. Journal of Psychosomatic Research, 25, 33-41.
9. Autran, B., Mathez, D., Carcelain, G., Blanc, C., Debre, P., & Leibowitch, J. (1997, January). Dynamics of the CD4 helper cell subset reconstitution after combined antiretroviral therapies. Paper presented at the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, DC.
10. Axelrod, J., & Reisine, T. (1984, May 4). Stress hormones: Their interaction and regulation. Science, 224, 452-459.
11. Baron, R., & Kenny, D. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51, 1173-1182.
12. Benson, H., & Klipper, M. (1976). The relaxation response. New York: Avon.
13. Berkenbosh, F. (1994). Corticotropin-releasing factor and catecholamines: A study on their role in stress-induced immunomodulation. In A. Baum & M. Stein (Eds.), Chronic stress and disease (pp. 73-91 ). Hillsdale, NJ: Erlbaum.
14. Bernstein, B., & Borkovec, T. (1973). Progressive relaxation training: A manual for the helping professions. Champaign, IL: Research Press.
15. Blendon, R. J., & Donelan, K. (1988). Discrimination against people with AIDS: The public's perspective. New England Journal of Medicine, 319, 1022-1026.
16. Bloom, D., & Carliner, G. (1988, February 5). The economic impact of AIDS in the United States. Science, 239, 604-609.
17. Brooks, G. R., & Richardson, F. C. (1980). Emotional skills training: A treatment program for duodenal ulcer. Behavior Therapy, 11, 198-207.
18. Brown, J. M. (1984). Imagery coping strategies in the treatment of migraine. Pain, 18, 157-167.
19. Bujatti, M., & Riederer, P. (1976). Serotonin, noradrenaline, dopamine metabolites in transcendental meditation technique. Journal of Neural Transmission, 39, 257-267.
20. Byrnes, D., Antoni, M. H., Goodkin, K., Efantis-Potter, J., Asthana, D., Simon, T., Munjai, J., Ironson, G., & Fletcher, M. A. (1998). Stressful events, pessimism, natural killer cell cytotoxicity and cytotoxic/suppressor T cells in HIV+ Black women at risk for cervical cancer. Psychosomatic Medicine, 60, 714-722.
21. Centers for Disease Control. (1992). Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report, 41, 1-19.
22. Centers for Disease Control. (1997). HIV/AIDS Surveillance Report, 9, 1-39.
23. Chambliss, D., & Hollon, S. (1998). Defining empirically supported therapies. Journal of Consulting and Clinical Psychology, 66, 7-18.
24. Chesney, M. A., & Folkman, S. (1994). Psychological impact of HIV disease and implications for intervention. Psychiatric Clinics of North America, 17, 163-182.
25. Cobb, S. (1974). Physiological changes in men whose jobs are abolished. Journal of Psychosomatic Research, 18, 245-258.
26. Cohen, S., Kamarck, T., & Mermelstein, R. (1983). A global measure of perceived stress. Journal of Health and Social Behavior, 24, 385-396.
27. Cohen, S., Tyrrell, D. A., & Smith, A. P. (1991). Psychological stress in humans and susceptibility to the common cold. New England Journal of Medicine, 325, 606-612.
28. Cole, S., Korin, Y., Fahey, J., & Zack, J. (1998). Norepinephrine accelerates HIV replication via protein kinase-A dependent effects on cytokine production. Journal of Immunology, 161, 610-616.
29. Compas, B., Haaga, D., Keefe, F., Leitenberg, H., & Williams, D. (1998). Sampling of empirically supported psychological treatments from health psychology: Smoking, chronic pain, cancer, and bulimia nervosa. Journal of Consulting and Clinical Psychology, 66, 89-112.
30. Cryer, P., Haymond, M., Santiago, J., & Shah, S. (1976). Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. New England Journal of Medicine, 295, 573-577.
31. Davidson, D., Winchester, M., Taylor, C., Alderman, E., & Ingels, N. (1979). Effects of relaxation therapy on cardiac performance and sympathetic activity in patients with organic heart disease. Psychosomatic Medicine, 41, 303-309.
32. Davidson, L., Fleming, R., & Baum, A. (1987. Summer). Chronic stress, catecholamines, and sleep disturbance at Three Mile Island. Journal of Human Stress, 13, 75-83.
33. Davis, M., Eshelman, E., & McKay, M. (1988). The relaxation and stress reduction workbook (3rd ed.). Oakland, CA: New Harbinger.
34. DeSchaepdryver, A., Hooft, D., Delbeke, M., & van den Noortgaete, M. (1978). Urinary catecholamines and metabolites in children. Journal of Pediatrics, 93, 266-268.
35. Dimsdale, J., & Moss, J. (1980). Plasma catecholamines in stress and exercise. JAMA, 243, 340-342.
36. Elenkov, I., Papanicolaou, D., Wilder, R., & Chrousos, G. (1996). Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications. Proceedings of the American Association of Physiology, 108, 374-381.
37. Esler, M., Jackman, G., Leonard, P., Skews, H., Bobik, A., & Korner, P. (1981). Effect of norepinephrine uptake blockers on norepinephrine kinetics. Clinical Pharmacology and Therapeutics, 29, 12-20.
38. Esterling, B., Antoni, M., Schneiderman, N., Ironson, G., LaPerriere, A., Klimas, N., & Fletcher, M. A. (1992). Psychosocial modulation of antibody to Epstein-Barr viral capsid antigen and herpes virus-Type 6 in HIV-1 infected and at-risk gay men. Psychosomatic Medicine, 54, 354-371.
39. Fawzy, F., Kemeny, M., Fawzy, N., & Elashoff, R. (1990). A structured psychiatric intervention for cancer patients: II. Changes over time in immunological measures. Archives of General Psychiatry, 47, 729-735.
40. Felten, D. (1996). Changes in the neural innervation of lymphoid tissues with age. In N. Hall, F. Altman, & S. Blumenthal (Eds.). Mind-body interactions and disease and psychoneuroimmunological aspects of health and disease (pp. 157-164). Washington, DC: Health Dateline Press.
41. Fletcher, M. A., Baron, G., Ashman, M., Fischl, M., & Klimas, N. (1987). Use of whole blood methods in assessment of immune parameters in immunodeficiency state. Diagnostic Clinical Immunology, 5, 69-81.
42. Folkman, S., Chesney, M., McKusick, L., Ironson, G., Johnson, D., & Coates, T. J. (1991). Translating coping theory into intervention. In J. Eckenrode (Ed.), The social contest of stress (pp. 239-260). New York: Plenum.
43. Folkman, S., Lazarus, R., Gruen, R., & DeLongis, A. (1986). Appraisal, coping, health status, and psychological symptoms. Journal of Personality and Social Psychology, 50, 571-579.
44. Folstein, M. F., Holstein, S. E., & McHugh, P. R. (1975). "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatry Research, 12, 189-198.
45. Gaulton, G., Scobie, J., & Rosenweig, M. (1997). HIV-1 and the thymus. AIDS, 11, 403-414.
46. Glaser, R., & Kiecolt-Glaser, J. (1987). Stress-associated depression in cellular immunity: Implications for acquired immune deficiency syndrome (AIDS). Brain Behavior and Immunity, 1, 107-112.
47. Glaser, R., & Kiecolt-Glaser, J. (1994). Handbook of human stress and immunity. New York: Academic Press.
48. Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50-55.
49. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56-62.
50. Hollon, S. (1996). The efficacy and effectiveness of psychotherapy relative to medications. American Psychologist, 51, 1025-1030.
51. Ironson, G., Antoni, M., & Lutgendorf, S. (1995). Can psychological interventions affect immunity and survival? Present findings and suggested targets with a focus on cancer and human immunodeficiency virus. Mind/Body Medicine, 1, 85-110.
52. Ironson, G., Field, T., Scafidi, F., Hashimoto, M., Kumar, M., Kumar, A., Price, A., Goncalves, A., Burman, I., Tatenman, C., Patarca, R., & Flecther, M. A. (1996). Massage therapy is associated with enhancement of the immune system's cytotoxic capacity. International Journal of Neuroscience, 84, 205-217.
53. Irvine, M., Johnston, D., Jenner, D., & Marie, G. (1986). Relaxation and stress management in the treatment of essential hypertension. Journal of Psychosomatic Research, 30, 437-450.
54. Kelly, J., Murphy, D., Bahr, R., Kalichman, S., Morgan, M., Stevenson, L., Koob, J., Brasfield, T., & Bernstein, B. (1993). Outcome of cognitive-behavioral and support group brief therapies for depressed HIV-infected persons. American Journal of Psychiatry, 150, 1679-1686.
55. Kennedy, B., Ziegler, M., & Shannahoff-Khalsa, D. (1986). Alternating lateralization of plasma catecholamines and nasal patency in humans. Life Sciences, 38, 1203-1214.
56. Kiecolt-Glaser, J., & Glaser, R. (1995). Psychoneuroimmunology and health consequences: Data and shared mechanisms. Psychosomatic Medicine, 57, 269-274.
57. Kilbourn, K., Costello, N., Antoni, M. H., Ironson, G., Fletcher, M. A., & Schneiderman, N. (1994, April). The physiological and psychological impact of Hurricane Andrew on an HIV positive population as compared to other stressed populations. Paper presented at the annual scientific meeting of the Society of Behavioral Medicine, Boston, MA.
58. Kumar, A., Kumar, M., Fernandez, J., Mellman, T., & Eisdorfer, C. (1991). A simplified HPLC-ECD technique for measurement of urinary free catecholamines. Journal of Liquid Chromatography, 14, 3547-3557.
59. Kumar, A., Kumar, M., Fernandez, J., Schneiderman, N., & Eisdorfer, C. (1993). An improved assay of urinary catecholamine metabolites, 3-methoxy-4-hydroxyphenyglycol and vanillylmandelic acid, using high performance liquid chromatograpy with electrochemical detection. Journal of Liquid Chromatography, 16, 1329-1340.
60. Kumar, M., Morgan, R., Szapocznik, J., & Eisdorfer, C. (1991). Norepinephrine response in HIV+ subjects. Journal of AIDS, 4, 782-785.
61. Landmann, R. (1992). Beta-adrenergic receptors in human leukocyte subpopulations. European Journal of Clinical Investigations, 22, S1-S3.
62. Lee, D., DeQuattro, V., Davison, G., Kimura, S., Barndt, R., & Sullivan, P. (1988). Noradrenergic hyperactivity in primary hypertension: Central and peripheral markers of both behavioral pathogenesis and efficacy of sympatholytic and relaxation therapy. Clinical Experimental Hypertension, 10, 225-234.
63. Leserman, J., Petitto, J., Perkins, D., Folds, J., Golden, R., & Evans, D. (1997). Severe stress, depressive symptoms and changes in lymphocyte subsets in human immunodeficiency virus-infected men: A 2-year follow-up study. Archives of General Psychiatry, 54, 279-285.
64. Lutgendorf, S., Antoni, M., Ironson, G., Klimas, N., Kumar, M., Starr, K., McCabe, P., Cleven, K., Fletcher, M. A., & Schneiderman, N. (1997). Cognitive behavioral stress management decreases dysphoric mood and herpes simplex virus-Type 2 antibody titers in symptomatic HIV-seropositive gay men. Journal of Consulting and Clinical Psychology, 65, 31-43.
65. Lutgendorf, S., Antoni, M. H., Ironson, G., Starr, K., Costello, N., Zuckerman, M., Klimas, N., Fletcher, M. A., & Schneiderman, N. (1998). Changes in cognitive coping skills and social support mediate distress outcomes in symptomatic HIV-seropositive gay men during a cognitive behavioral stress management intervention. Psychosomatic Medicine, 60, 204-214.
66. Lutgendorf, S., Antoni, M. H., Schneiderman, N., & Fletcher, M. A. (1994). Psychosocial counseling to improve quality of life in HIV-infected gay men. Patient Education and Counseling, 24, 217-235.
67. Luthe, W. (1969). Autogenic therapy. New York: Grune & Stratton.
68. Madden, K., Sanders, V., & Felten, D. (1995). Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annual Review of Pharmacology and Toxicology, 35, 417-448.
69. Maher, K., Klimas, N., Dickinson, G., Triplett, J., Maggio, C., Valenzuela, R., & Fletcher, M. A. (1997). T lymphocyte subsets and highly active antiretroviral therapy (HAART) of HIV infection. Cytometry, 30, 345.
70. Marks, J. (1991). Endocrine manifestations of human immunodeficiency virus (HIV) infection. American Journal of the Medical Sciences, 302, 110-117.
71. Martin, J. (1988). Psychological consequences of AIDS-related bereavement among gay men. Journal of Consulting and Clinical Psychology, 56, 856-862.
72. Mason, J. A. (1986). Guide to stress reduction (pp. 26-79). Berkeley, CA: Celestial Arts.
73. McCabe, P. M., & Schneiderman, N. (1985). Psychophysiologic reactions to stress. In N. Schneiderman & J. T. Tapp (Eds.), Behavioral medicine: The biopsychosocial approach (pp. 99-131). Hillsdale, NJ: Erlbaum.
74. McCain, N., Zeller, J., Cella, D., Urbanski, P., & Novak, R. (1996). The influence of stress management training in HIV disease. Nursing Research, 45, 246-253.
75. McCoy, G., Blanchard, E., Wittrock, D., Morrison, S., Pangburn, L., Siracua, K., & Pallmeyer, T. (1988). Biochemical changes associated with thermal biofeedback treatment of hypertension. Biofeedback and Self-Regulation, 13, 139-150.
76. McEwen, B. (1998). Protective and damaging effects of stress mediators. New England Journal of Medicine, 338, 171-179.
77. McEwen, B., & Stellar, E. (1993). Stress and the individual: Mechanisms leading to disease. Archives of Internal Medicine, 153, 2093-2101.
78. McGrady, A., Woerner, M., Bernal, G. A. A., & Higgins, J. T. (1987). Effect of biofeedback-assisted relaxation on blood pressure and cortisol levels in normotensives and hypertensives. Journal of Behavioral Medicine, 10, 301-310.
79. McKinney, C., Antoni, M. H., Kumar, M., Tims, F., & McCabe, P. (1997). Effects of guided imagery and music (GIM) therapy on mood and cortisol in healthy adults. Health Psychology, 16, 1-12.
80. McNair, D., Lorr, M., & Droppleman, L. (1981). EDITS manual for the Profile of Mood States. San Diego, CA: EDITS.
81. Mills, P., Ziegler, M., Patterson, T., Dimsdale, J., Hauger, R., Irwin, M., & Grant, I. (1997). Plasma catecholamine and lymphocyte beta 2-adrenergic receptor alterations in elderly Alzheimer caregivers under stress. Psychosomatic Medicine, 59, 251-256.
82. Mokel, M., Stork, T., Vollert, J., Rocker, L., Danne, O., Hochrein, H., Eichstadt, H., & Frei, U. (1995). Stress reduction through listening to music: Effects on stress hormones, hemodynamics and mental state in patients with arterial hypertension and in healthy persons. German Medical Journal, 120, 745-752.
83. Mulder, C. L., Emmelkamp, P., Antoni, M. H., Mulder, J., Sandfort, T., & de Vries, M. (1994). Cognitive-behavioral and experiential group psychotherapy for HIV-infected homosexual men: A comparative study. Psychosomatic Medicine, 56, 423-431.
84. Musey, L., Hughes, J., Schacker, T., Shea, T., Corey, L., & McElrath, M. J. (1997). Cytotoxic T-cell responses, viral load and disease progression in early human immunodeficiency virus Type I infection. New England Journal of Medicine, 337, 1267-1274.
85. Namir, S., Wolcott, D. L., Fawzy, F. I., & Alumbaugh, M. J. (1987). Coping with AIDS: Psychological and health implications. Journal of Applied Social Psychology, 17, 309-328.
86. Oldstone, M. B. (1997). HIV versus cytotoxic T-lymphocytes - The war being lost. New England Journal of Medicine, 337, 1306-1308.
87. Pema, F., Antoni, M. H., Kumar, M., Cruess, D., & Schneiderman, N. (1998). Cognitive behavioral intervention effects on mood and cortisol during athletic training. Annals of Behavioral Medicine, 20, 92-98.
88. Rabkin, J., Wagner, G., & Rabkin, R. (1996). Treatment of depression in HIV + men: Literature review and report of an ongoing study of testosterone replacement therapy. Annals of Behavioral Medicine, 18, 24-29.
89. Redfield, R., & Burke, D. (1988). HIV infection: The clinical picture. Scientific American, 259, 90-98.
90. Robertson, D., Frolich, J., Carr, R., Watson, J., Hollifield, J., Shand, D., & Oates, J. (1978). Effects of caffeine on plasma renin activity, catecholamines, and blood pressure. New England Journal of Medicine, 298, 181-186.
91. Schedlowski, M., Jungk, C., Schimanski, G., Tewes, U., & Schmoll, H. J. (1994). Effects of behavioral intervention on plasma cortisol and lymphocytes in breast cancer patients: An exploratory study. Psycho-Oncology, 3, 181-187.
92. Schmidt, T., Wijga, A., von zur Mulen, A., Brabant, G., & Wagner, T. (1997). Changes in cardiovascular risk factors and hormones during a comprehensive residential three month kriya yoga training and vegetarian nutrition. Acta Physiologica. Scandinavica, 161, 158-162.
93. Schneiderman, N., Antoni, M. H., & Ironson, G. (1997). Cognitive behavioral stress management and secondary prevention in HIV/AIDS. Psychology and AIDS Exchange, 22, 1-8.
94. Sikkema, K., & Kelly, J. (1996). Behavioral medicine interventions can improve quality of life and health of persons with HIV disease. Annals of Behavioral Medicine, 18, 40-48.
95. Spielberger, C., Gorsuch, R., & Lushene, R. (1970). STAI manual. Palo Alto, CA: Consulting Psychologists Press.
96. Spitzer, R., Williams, J., Gibbon, M., & First, M. (1988). Structured Clinical Interview for DSM-III-K: Nonpatient version for HIV studies (SCID-NP-HIV 6/1/88). New York: New York Psychiatric Institute, Biometrics Research Department.
97. Spitzer, R., Williams, J., Gibbon, M., & First, M. (1990). Structured Interview for DSM-III-R: Personality disorders (SCID-II). New York: New York State Psychiatric Institute, Biometrics Research Department.
98. Starr, K., Antoni, M. H., Hurwitz, B., Rodriquez, M., Ironson, G., Fletcher, M. A., Kumar, M., Patarca, R., Lutgendorf, S., Quillian, R., Klimas, N., & Schneiderman, N. (1996). Patterns of immune, neuroendocrine, and cardiovascular stress responses in HIV seropositive and seronegative men. International Journal of Behavioral Medicine, 3, 135-162.
99. Surwit, R., Pilon, R., & Fenton, C. (1978). Behavioral treatment of Raynaud's disease. Journal of Behavioral Medicine, 1, 323-335.
100. Turk, D., Holzman, A., & Kerns, R. (1986). Chronic pain. In K. Holroyd & T. Creer (Eds.), Self-management of chronic disease: Handbook of clinical interventions and research. Orlando, FL: Academic Press.
101. Webster, E., Elenkov, I., & Chrousos, G. (1997). The role of corticotropin-releasing hormone in neuroendocrine-immune interactions. Molecular Psychiatry, 2, 368-372.
102. Williams, J. (1988). Structured interview guide for the Hamilton Anxiety and Depression Rating Scales. Archives of General Psychiatry, 45, 742.
103. Williams, J., Rabkin, J., & Remien, R. (1991). Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection: II. Standardized clinical assessment of current and lifetime psychopathology. Archives of General Psychiatry, 48, 124-130.
104. Wong, J., Hezareh, M., Gunthard, H., Havlir, D. V., Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997, November 14). Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science, 278, 1291-1295.
105. Ziegler, M. (1989). Catecholamine measurement in behavioral research. In N. Schneiderman & P. Kauffman (Eds.), Handbook of cardiovascular methods (pp. 99-131). New York: Plenum.
106. Ziegler, M., Lake, C., & Ebert, M. (1979). Norepinephrine elevations in cerebrospinal fluid after D- and L-amphetamine. European Journal of Pharmacology, 57, 127-133.
107. Ziegler, M., Lake, C., & Kopin, I. (1976, May 27). Plasma noradrenaline increases with age. Nature, 261, 333-335.
108. Ziegler, M., Milano, A., & Hull, E. (1985). The catecholaminergic response to stress and exercise. In C. Lake & M. Ziegler (Eds.), The catecholamines in psychiatric and neurologic disorders (pp. 37-53). Woburn, MA: Butterworth-Heinemann.